TrialAssure launches TrialResults.com for Clinical Trial Sponsors to Publicly Post Plain Language Summaries
TrialResults.com helps lead the way in assisting clinical trial
sponsors to #BeTransparent
AMSTERDAM & CANTON, Mich.–(BUSINESS WIRE)–#BeTransparent–TrialAssure® – a leading, global software company focused on developing
clinical trial transparency tools – announced today the launch of
TrialResults.com, a new portal for sponsors to publicly share plain
language, or lay, summaries with clinical trial participants. This
portal allows trial participants to access the plain language summaries
in any region of the world and in their native language with ease,
simultaneously reducing the burden for sponsors who do not have their
own public portal.
TrialResults.com makes the communication process easier for sponsors. In
place of mailing paper copies of the plain language summaries to
participants, sponsors can simply upload the summary onto the portal,
saving both time and money. Additionally, timely posting of these
results in a way that is understandable to all participants will lead to
a more positive clinical trial experience and strengthen support for
future participation and public perception of health sciences research
overall.
Using TrialResults.com takes just three easy steps:
- Clinical research organizations and sponsors upload completed plain
language summaries onto the portal - Users enter the unique trial identifier that has been provided to them
into the search bar - The relevant plain language summary appears
“TrialAssure is acutely focused on making it simple for all clinical
trial sponsors to be transparent, providing the most effective and
affordable tools in the industry,” said Zach Weingarden, Product
Solutions Manager, TrialAssure. “TrialResults.com is the next
advancement in our transparency suite and is game-changing for sponsors
who do not have a place to otherwise publish their trial results.”
Currently, only 2 percent of clinical trial sponsors have issued plain
language summaries to participants in the past few years, as recently
reported by Applied Clinical Trials. For many trial participants, trying
to understand the clinical trial results as posted to government
clinical trial registries can be difficult, given the highly technical
scientific jargon. TrialResults.com provides the same information in
everyday language for reading and download at any time.
“TrialResults.com comes at a crucial time in the pharmaceutical industry
when the requirement for posting lay summaries is looming,” said Alan
Nicolle, Director, Business Development & Business Alliance Partnerships
at TrialAssure in London. “TrialResults.com is a seamless transition for
sponsors. My recommendation to sponsors is to stay ahead of the game by
sharing results now rather than wait for legislation to mandate it.”
Available now!
TrialResults.com is available now for use by pharmaceutical companies,
universities, clinical research organizations, and all others conducting
clinical trials. Stay ahead of global transparency regulations and
connect with trial participants – request a free demo at www.trialresults.com.
About TrialAssure
TrialAssure is a global clinical trial disclosure and transparency
reporting suite with unmatched experience in helping clients navigate
complex regulatory submission and reporting challenges. TrialAssure
helps meet regulatory compliance goals through a flexible, scalable, and
streamlined platform that regularly adapts to ever-changing clinical
trial disclosure requirements. Established in 2009, TrialAssure was
built from the ground up as a single, integrated transparency system,
and it is continually strengthened by the experience of leading
pharmaceutical industry compliance experts. For more information, visit: www.trialassure.com.
Contacts
Media contact
Don McLean, MBA
+1-734-245-0165
media@trialassure.com
Thank you for donating to DutchNews.nl.
We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.
Make a donation